{
    "organizations": [],
    "uuid": "91d3206a73c794e807a1d4e909779cb51d542b15",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-anaptysbio-announces-positive-top/brief-anaptysbio-announces-positive-top-line-proof-of-concept-data-for-anb020-in-moderate-to-severe-baseline-adult-peanut-allergy-patients-idUSFWN1R80YE",
    "ord_in_thread": 0,
    "title": "BRIEF-Anaptysbio Announces Positive Top-Line Proof-Of-Concept Data For ANB020 In Moderate-To-Severe Baseline Adult Peanut Allergy Patients",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Anaptysbio Inc:\n* ANAPTYSBIO ANNOUNCES POSITIVE TOP-LINE PROOF-OF-CONCEPT DATA FOR ANB020 IN MODERATE-TO-SEVERE BASELINE ADULT PEANUT ALLERGY PATIENTS\n* ANAPTYSBIO INC - ‍ANB020 WAS WELL TOLERATED AND NO PATIENTS HAVE DISCONTINUED FROM STUDY​\n* ANAPTYSBIO INC - ‍ANAPTYSBIO PLANS TO INITIATE A MULTI-DOSE PHASE 2B TRIAL IN MODERATE-TO-SEVERE BASELINE ADULT PEANUT ALLERGY PATIENTS​\n* ANAPTYSBIO INC - ‍NO SERIOUS ADVERSE EVENTS HAVE BEEN REPORTED FROM STUDY​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-27T04:07:00.000+03:00",
    "crawled": "2018-03-27T11:48:55.031+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "anaptysbio",
        "inc",
        "anaptysbio",
        "announces",
        "positive",
        "data",
        "anb020",
        "baseline",
        "adult",
        "peanut",
        "allergy",
        "patient",
        "anaptysbio",
        "inc",
        "well",
        "tolerated",
        "patient",
        "discontinued",
        "anaptysbio",
        "inc",
        "plan",
        "initiate",
        "phase",
        "2b",
        "trial",
        "baseline",
        "adult",
        "peanut",
        "allergy",
        "anaptysbio",
        "inc",
        "serious",
        "adverse",
        "event",
        "reported",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}